Messenger RNA, or mRNA, plays a fundamental role in human biology, transferring the instructions stored in DNA to create the proteins required in every living cell. Therefore, given the right approach and infrastructure mRNA medicines could instruct a patient’s own cells to produce proteins that could prevent, treat, or cure disease and thereby meaningfully improve how medicines are discovered, developed and manufactured.
Join Jim Thompson, CMC Therapeutic Area Lead at Moderna, during this free interactive broadcast as he discusses historical case examples of the Moderna mRNA technology platform for the development of prophylactic vaccines and in situ production of neutralizing antibodies for passive immunity and therapeutic applications.
What You Will Learn
- Basics of Moderna’s mRNA platform technology
- Nonclinical and clinical data from Moderna vaccines
- Historical case studies of CMV and Chikungunya development